Linda Henry

5 ta ish

Inova Health System

1. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

   Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif +3

   Sharh maqola201510 iqtibos

   ABIABI:AkademIndex/2026.other.003638

2. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

   Zobair M. Younossi, Pegah Golabi, James M. Paik +3

   Sharh maqolaOAOchiq kirish20235 iqtibos

   ABIABI:AkademIndex/2026.other.008447

3. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

   Zobair M. Younossi, Deirdre B Blissett, Robert Blissett +6

   MaqolaOAOchiq kirish20164 iqtibos

   ABIABI:AkademIndex/2026.other.003667

4. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

   Zobair M. Younossi, Quentin M. Anstee, M. Marietti +5

   Sharh maqolaOAOchiq kirish20174 iqtibos

   ABIABI:AkademIndex/2026.other.003684

5. Epidemiology of chronic liver diseases in the USA in the past three decades

   Zobair M. Younossi, Maria Stepanova, Youssef Younossi +4

   Maqola20193 iqtibos

   ABIABI:AkademIndex/2026.other.723603